Showing results (1581-1590 of 3,871) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|June 25, 2010
The use of 5-alpha reductase inhibitors for the prevention of prostate cancerEun-mi Yu, Walid El-Ayass, Jeanny B Aragon-ChingCancer Biology & Therapy|June 25, 2010
VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cellsLymor Ringer, Paul Sirajuddin, Venkata Mahidhar Yenugonda, et al.Cancer Biology & Therapy|August 11, 2010
Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patientsPierpaolo Correale, Cinzia Remondo, Salvatore Francesco Carbone, et al.Cancer Biology & Therapy|August 13, 2010
Theraputic targeting of Trk supresses tumor proliferation and enhances cisplatin activity in HNSCCTurker Yilmaz, Tilahun Jiffar, Gabriel de la Garza, et al.Cancer Biology & Therapy|August 6, 2010
Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivoSha Hu, Lili Yu, Zhimin Li, et al.Cancer Biology & Therapy|August 12, 2010
Extrapleural pneumonectomy, photodynamic therapy and intensity modulated radiation therapy for the treatment of malignant pleural mesotheliomaKevin L Du, Stefan Both, Joseph S Friedberg, et al.Cancer Biology & Therapy|August 12, 2010
Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cellsHua Li, Xuelian Zhang, Lauren Fishbein, et al.Cancer Biology & Therapy|September 7, 2010
Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in miceAnwaar Ahmad, Jason S Groshong, Hittu Matta, et al.Cancer Biology & Therapy|June 15, 2010
Apoptosis induction of ZBB-006, a novel synthetic diterpenoid, in the human hepatocellular carcinoma cell line HepG2 in vitro and in vivoQian-Qian Fan, Qiu-Juan Wang, Bu-Bing Zeng, et al.Pageof 388